Oscar Paredes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Oscar Paredes has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Carlos Luque-Vasquez
Department of Abdominal Surgery, National Institute of Neoplastic Diseases INEN, Lima, Peru
5 shared publicationsEduardo Payet
Department of Abdominal Surgery, National Institute of Neoplastic Diseases INEN, Lima, Peru
5 shared publicationsEloy Ruiz
Department of Abdominal Surgery, National Institute of Neoplastic Diseases INEN, Lima, Peru
5 shared publicationsFrancisco Berrospi
Department of Abdominal Surgery, National Institute of Neoplastic Diseases INEN, Lima, Peru
5 shared publicationsYoshikuni Kawaguchi
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
4 shared publicationsIvan Chavez
Instituto Nacional de Enfermedades Neoplasicas
3 shared publications
Latest Publications
- Open Access
- 6 May 2022
- Published by Springer Nature in Research Square
Analysis of risk factors for lymphatic metastasis in patients diagnosed with early gastric cancer
Purpose This study aimed to identify the clinicopathological factors associated with the presence of lymph node metastasis (LNM) in patients diagnosed with early gastric cancer (EGC) and treated with radical gastrectomy. Methods Patients who underwent radical gastrectomy for gastric cancer from January 1990 to December 2019 were identified from a prospectively compiled database.Patients with pathological diagnoses of EGC were included. Univariate and multivariate analyses were conducted to identify risk factors associated with LNM. Results From 501 patients with EGC, 96(19.2%) presented LNM.In 279 patients with tumors with submucosal infiltration(T1b), 83(30%) patients had LNM. Among 219 patients who presented tumors > 3cm, 63(29%) patients had LNM. Thirty-one percent of patients with ulcerated tumors presented LMN(33 out of 105). In 76 patients and 24 patients with lymphovascular and perineural invasion, the percentage of LMN was 84% and 87%,respectively. In the univariate analysis, tumor diameter > 3cm, undifferentiated tumors, ulcerated tumors, submucosal invasion, lymphovascular, and perineural invasion showed a significant association with the presence of LNM.In the multivariate analysis, a tumor size > 3cm, submucosal invasion, lymphovascular, and perineural invasion were independent predictors of LMN in EGC. Patients who presented differentiated tumors, without ulceration, infiltration of the mucosa, and a tumor diameter ≤ 2cm, none presented LNM. Four patients(3%) who complied with the new Japanese indications for endoscopic treatment presented LNM. Conclusions The presence of lymph node metastasis in patients with EGC was independently related to larger tumors (tumor diameter > 3cm), submucosal invasion, lymphovascular and perineural invasion.
- 6 May 2022
- Published by Springer Nature in Research Square
Open AccessAnalysis of risk factors for lymphatic metastasis in patients diagnosed with early gastric cancer
Purpose This study aimed to identify the clinicopathological factors associated with the presence of lymph node metastasis (LNM) in patients diagnosed with early gastric cancer (EGC) and treated with radical gastrectomy. Methods Patients who underwent radical gastrectomy for gastric cancer from January 1990 to December 2019 were identified from a prospectively compiled database.Patients with pathological diagnoses of EGC were included. Univariate and multivariate analyses were conducted to identify risk factors associated with LNM. Results From 501 patients with EGC, 96(19.2%) presented LNM.In 279 patients with tumors with submucosal infiltration(T1b), 83(30%) patients had LNM. Among 219 patients who presented tumors > 3cm, 63(29%) patients had LNM. Thirty-one percent of patients with ulcerated tumors presented LMN(33 out of 105). In 76 patients and 24 patients with lymphovascular and perineural invasion, the percentage of LMN was 84% and 87%,respectively. In the univariate analysis, tumor diameter > 3cm, undifferentiated tumors, ulcerated tumors, submucosal invasion, lymphovascular, and perineural invasion showed a significant association with the presence of LNM.In the multivariate analysis, a tumor size > 3cm, submucosal invasion, lymphovascular, and perineural invasion were independent predictors of LMN in EGC. Patients who presented differentiated tumors, without ulceration, infiltration of the mucosa, and a tumor diameter ≤ 2cm, none presented LNM. Four patients(3%) who complied with the new Japanese indications for endoscopic treatment presented LNM. Conclusions The presence of lymph node metastasis in patients with EGC was independently related to larger tumors (tumor diameter > 3cm), submucosal invasion, lymphovascular and perineural invasion.
- Open Access
- 22 November 2021
- Published by Springer Nature in Discover Oncology
- Vol. 12 (1) , 1-12
Clinicopathological factors associated with recurrence in patients undergoing resection of pancreatic solid pseudopapillary neoplasm
Purpose: Solid pseudopapillary neoplasm (SPN) is an uncommon pathology with a low-grade malignancy. Surgery is the milestone treatment. Nevertheless, despite appropriate management, some patients present recurrence. Risk factors associated with recurrence are unclear. The objective was to identify the clinicopathological factors associated with recurrence in patients with SPN treated with pancreatic resection. Methods: Medical records of patients treated with pancreatic resection during 2006–2020 were evaluated. Patients with histological diagnosis of SPN were included. Survival analysis was performed to identify the clinicopathological factors related to recurrence. Results: Seventy-four patients were diagnosed with SPN; 70 (94.6%) patients were female, and the median age was 20 years old. The median tumor diameter was 7.9 cm. Multivisceral resection was performed in 9 (12.2%) patients. Four (5.4%) patients presented lymph node metastasis.R0 resection was achieved in all cases. Six (8%) patients presented recurrence and the liver was the most frequent recurrence site (n = 5).After a median follow-up of 40.2 months, 9 (12%) patients died. Five (6.8%) patients died of disease progression. The 1–3- and 5-year overall survival (OS) was 97.1%, 90.2% and 79.9%, respectively. The 1–3-and-5-year recurrence-free survival (RFS) was 98.4%, 89.9% and 87%, respectively. In the univariate Cox-regression analysis, age ≥ 28 years(HR = 8.61, 95% CI 1.1–73.8),tumor diameter ≥ 10 cm(HR = 9.3, 95% CI 1.12–79.6),invasion of adjacent organs (HR = 7.45, 95% CI 1.5–36.9), lymph node metastasis (pN +) (HR = 16.8, 95% CI 2.96–94.9) and, AJCC Stage III (HR = 10.1, 95% CI 1.2–90.9) were identified as predictors for recurrence. Conclusions: SPN is more frequently diagnosed in young women with a good overall prognosis after an R0 surgical resection even with disease recurrence. Age ≥ 28 years, larger tumors ≥ 10 cm, invasion of adjacent organs, lymph node metastasis(pN +) and, AJCC Stage III were predictors factors of recurrence in resected SPN.
- 22 November 2021
- Published by Springer Nature in Discover Oncology
- Vol. 12 (1) , 1-12
Open AccessClinicopathological factors associated with recurrence in patients undergoing resection of pancreatic solid pseudopapillary neoplasm
Purpose: Solid pseudopapillary neoplasm (SPN) is an uncommon pathology with a low-grade malignancy. Surgery is the milestone treatment. Nevertheless, despite appropriate management, some patients present recurrence. Risk factors associated with recurrence are unclear. The objective was to identify the clinicopathological factors associated with recurrence in patients with SPN treated with pancreatic resection. Methods: Medical records of patients treated with pancreatic resection during 2006–2020 were evaluated. Patients with histological diagnosis of SPN were included. Survival analysis was performed to identify the clinicopathological factors related to recurrence. Results: Seventy-four patients were diagnosed with SPN; 70 (94.6%) patients were female, and the median age was 20 years old. The median tumor diameter was 7.9 cm. Multivisceral resection was performed in 9 (12.2%) patients. Four (5.4%) patients presented lymph node metastasis.R0 resection was achieved in all cases. Six (8%) patients presented recurrence and the liver was the most frequent recurrence site (n = 5).After a median follow-up of 40.2 months, 9 (12%) patients died. Five (6.8%) patients died of disease progression. The 1–3- and 5-year overall survival (OS) was 97.1%, 90.2% and 79.9%, respectively. The 1–3-and-5-year recurrence-free survival (RFS) was 98.4%, 89.9% and 87%, respectively. In the univariate Cox-regression analysis, age ≥ 28 years(HR = 8.61, 95% CI 1.1–73.8),tumor diameter ≥ 10 cm(HR = 9.3, 95% CI 1.12–79.6),invasion of adjacent organs (HR = 7.45, 95% CI 1.5–36.9), lymph node metastasis (pN +) (HR = 16.8, 95% CI 2.96–94.9) and, AJCC Stage III (HR = 10.1, 95% CI 1.2–90.9) were identified as predictors for recurrence. Conclusions: SPN is more frequently diagnosed in young women with a good overall prognosis after an R0 surgical resection even with disease recurrence. Age ≥ 28 years, larger tumors ≥ 10 cm, invasion of adjacent organs, lymph node metastasis(pN +) and, AJCC Stage III were predictors factors of recurrence in resected SPN.
- Open Access
- 14 June 2021
- Published by Springer Nature in Research Square
Clinicopathological Factors Associated with Recurrence in Patients Undergoing Resection of Pancreatic Solid Pseudopapillary Neoplasm
Background: Solid pseudopapillary neoplasm (SPN) is an uncommon pathology with a low-grade malignancy. Surgery is the milestone treatment. Nevertheless, despite appropriate management, some patients present recurrence. Risk factors associated with recurrence are unclear. The objective of this study was to identify the clinicopathological factors associated with recurrence in patients with the diagnosis of SPN treated with pancreatic resection.Methods: In this retrospective single-center study, medical records of patients treated with pancreatic resection from January 2006 to January 2020 were evaluated. Patients with histological diagnosis of SPN were included. Survival analysis was performed to identify the clinicopathological factors related to recurrence.Results: A total of 589 patients underwent pancreatectomy and, 74(12.6%) were diagnosed with SPN. Seventy patients (94.6%) were female and 4 were male. The median age was 20 years old and, 49(67%) patients were Conclusions: SPN is more frequently diagnosed in young women with a good overall prognosis after an R0 surgical resection even with disease recurrence. Age ≥28 years, larger tumors ≥10cm, invasion of adjacent organs, lymph node metastasis(N+) and, AJCC Stage III were predictors factors of recurrence in resected SPN.
- 14 June 2021
- Published by Springer Nature in Research Square
Open AccessClinicopathological Factors Associated with Recurrence in Patients Undergoing Resection of Pancreatic Solid Pseudopapillary Neoplasm
Background: Solid pseudopapillary neoplasm (SPN) is an uncommon pathology with a low-grade malignancy. Surgery is the milestone treatment. Nevertheless, despite appropriate management, some patients present recurrence. Risk factors associated with recurrence are unclear. The objective of this study was to identify the clinicopathological factors associated with recurrence in patients with the diagnosis of SPN treated with pancreatic resection.Methods: In this retrospective single-center study, medical records of patients treated with pancreatic resection from January 2006 to January 2020 were evaluated. Patients with histological diagnosis of SPN were included. Survival analysis was performed to identify the clinicopathological factors related to recurrence.Results: A total of 589 patients underwent pancreatectomy and, 74(12.6%) were diagnosed with SPN. Seventy patients (94.6%) were female and 4 were male. The median age was 20 years old and, 49(67%) patients were Conclusions: SPN is more frequently diagnosed in young women with a good overall prognosis after an R0 surgical resection even with disease recurrence. Age ≥28 years, larger tumors ≥10cm, invasion of adjacent organs, lymph node metastasis(N+) and, AJCC Stage III were predictors factors of recurrence in resected SPN.
- 19 March 2021
- Published by Springer Nature in Pediatric Surgery International
- Vol. 37 (8) , 1041-1047
Surgery of pancreas tumors in pediatric and adolescent patients: a single institution experience in South America
Purpose Pancreas tumors are extremely rare in pediatric and adolescent patients. Surgical resection is the mainstay of treatment; however, the data are limited with respect to morbidity and mortality. We aimed to evaluate short- and long-term outcomes of pediatric and adolescent patients who underwent surgical resection of pancreatic tumors. Methods Patients \(\le\) 18-year-olds who underwent resection of pancreas tumor at the National Institute of Neoplastic Diseases INEN during 2000–2020 were included. Results Thirty-four patients were diagnosed; 28 patients were female and 6 were male. The median age was 13.4-years-old. Histological diagnosis was solid pseudopapillary neoplasm (SPN) (n = 29, 85.3%), pancreatoblastoma (n = 3), neuroendocrine carcinoma (n = 1), and insulinoma (n = 1). No patient experienced postoperative mortality and 15 (44.1%) patients developed postoperative complications including pancreatic fistula as the most frequent. Under a median follow-up period of 33.8 (0.5–138) months, four (11.8%) patients died. Of the 29 patients with SPN, the 3- and-5-year OS rates were 100% and 83.1%, respectively. Conclusions SPN was the most frequent cause of surgical treatment for pediatric and adolescent patients in the high-volume cancer center in Peru and was associated with favorable survival. Pancreaticoduodenectomy was safely performed in this patient group with acceptable morbidity and zero mortality.- 19 March 2021
- Published by Springer Nature in Pediatric Surgery International
- Vol. 37 (8) , 1041-1047
Surgery of pancreas tumors in pediatric and adolescent patients: a single institution experience in South America
Purpose Pancreas tumors are extremely rare in pediatric and adolescent patients. Surgical resection is the mainstay of treatment; however, the data are limited with respect to morbidity and mortality. We aimed to evaluate short- and long-term outcomes of pediatric and adolescent patients who underwent surgical resection of pancreatic tumors. Methods Patients \(\le\) 18-year-olds who underwent resection of pancreas tumor at the National Institute of Neoplastic Diseases INEN during 2000–2020 were included. Results Thirty-four patients were diagnosed; 28 patients were female and 6 were male. The median age was 13.4-years-old. Histological diagnosis was solid pseudopapillary neoplasm (SPN) (n = 29, 85.3%), pancreatoblastoma (n = 3), neuroendocrine carcinoma (n = 1), and insulinoma (n = 1). No patient experienced postoperative mortality and 15 (44.1%) patients developed postoperative complications including pancreatic fistula as the most frequent. Under a median follow-up period of 33.8 (0.5–138) months, four (11.8%) patients died. Of the 29 patients with SPN, the 3- and-5-year OS rates were 100% and 83.1%, respectively. Conclusions SPN was the most frequent cause of surgical treatment for pediatric and adolescent patients in the high-volume cancer center in Peru and was associated with favorable survival. Pancreaticoduodenectomy was safely performed in this patient group with acceptable morbidity and zero mortality.- Open Access
- 5 February 2021
- Published by Springer Nature in Research Square
Surgery of pancreas tumors in pediatric and adolescent patients: a single institution experience in South America
Purpose Pancreas tumors are extremely rare in pediatric and adolescent patients. Surgical resection is the mainstay of treatment; however, the data is limited with respect to morbidity and mortality. We aimed to evaluate short- and long-term outcomes of pediatric and adolescent patients who underwent surgical resection of pancreatic tumors. Methods Patients \(\le\) 18 years old who underwent resection of pancreas tumor at the National Institute of Neoplastic Diseases INEN during 2000–2020 were included. Results Thirty-four patients were diagnosed; 28 patients were female and 6 were male. The median age was 13.4 years old. Histological diagnosis was solid pseudopapillary neoplasm (SPN) (n = 29,85.3%), pancreatoblastoma (n = 3), neuroendocrine carcinoma (n = 1), and insulinoma (n = 1). No patient experienced postoperative mortality and 15 (44.1%) patients developed postoperative complications including pancreatic fistula as the most frequent. Under a median follow-up period of 33.8 (0.5–138) months, 4 (11.8%) patients died. Of the 29 patients with SPN, the 3-and-5-year OS was 100% and 83.1%, respectively. Conclusions SPN was the most frequent cause of surgical treatment for pediatric and adolescent patients in the high-volume cancer center in Peru and was associated with favorable survival. Pancreaticoduodenectomy was safely performed in this patient group with acceptable morbidity and zero mortality.- 5 February 2021
- Published by Springer Nature in Research Square
Open AccessSurgery of pancreas tumors in pediatric and adolescent patients: a single institution experience in South America
Purpose Pancreas tumors are extremely rare in pediatric and adolescent patients. Surgical resection is the mainstay of treatment; however, the data is limited with respect to morbidity and mortality. We aimed to evaluate short- and long-term outcomes of pediatric and adolescent patients who underwent surgical resection of pancreatic tumors. Methods Patients \(\le\) 18 years old who underwent resection of pancreas tumor at the National Institute of Neoplastic Diseases INEN during 2000–2020 were included. Results Thirty-four patients were diagnosed; 28 patients were female and 6 were male. The median age was 13.4 years old. Histological diagnosis was solid pseudopapillary neoplasm (SPN) (n = 29,85.3%), pancreatoblastoma (n = 3), neuroendocrine carcinoma (n = 1), and insulinoma (n = 1). No patient experienced postoperative mortality and 15 (44.1%) patients developed postoperative complications including pancreatic fistula as the most frequent. Under a median follow-up period of 33.8 (0.5–138) months, 4 (11.8%) patients died. Of the 29 patients with SPN, the 3-and-5-year OS was 100% and 83.1%, respectively. Conclusions SPN was the most frequent cause of surgical treatment for pediatric and adolescent patients in the high-volume cancer center in Peru and was associated with favorable survival. Pancreaticoduodenectomy was safely performed in this patient group with acceptable morbidity and zero mortality.